TherapeuticsMD
TXMD
#10158
Rank
NZ$33.6 M
Marketcap
NZ$2.90
Share price
0.00%
Change (1 day)
48.28%
Change (1 year)

EPS for TherapeuticsMD (TXMD)

EPS in 2025 (TTM): NZ-$0.08529

According to TherapeuticsMD's latest financial reports the company's current EPS (TTM) is NZ-$0.08694. In 2021 the company made an earnings per share (EPS) of NZ-$37.73 an increase over its 2020 EPS that were of NZ-$58.25.

EPS history for TherapeuticsMD from 2013 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$0.08529
2021NZ-$37.73-35.22%
2020NZ-$58.25-5.63%
2019NZ-$61.7220.34%
2018NZ-$51.2955.26%
2017NZ-$33.04-19.15%
2016NZ-$40.86-6%
2015NZ-$43.4742.86%
2014NZ-$30.4352.17%
2013NZ-$20.00

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Agile Therapeutics
AGRX
NZ-$6.73 7,640.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Lannett Company
LCI
NZ-$43.95 50,460.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.99-3,540.00%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$2.35-2,803.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
NZ$3.07-3,632.58%๐Ÿ‡ฌ๐Ÿ‡ง UK